Translate this page into:
Abnormal extraosseous activity in both lungs and stomach in pre-transplant 99mTc-MDP bone scan disappearing after renal transplant
Address for correspondence: Dr. Sunita Tarsarya Sonavane, Department of Nuclear Medicine and PET, Bombay Hospital and Medical Research Center, 12, Marine Lines, Mumbai - 400 020, Maharashtra, India. E-mail: drsunitatarsarya@yahoo.co.in
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Abstract
A chronic kidney disease male patient presenting with bone pains, fever, weakness, and clinically ascites was subjected to four technetium-99m-methylene diphosphonate (Tc99m-MDP) bone scans, two before renal transplant and two after renal transplants. Pretransplant bone scan revealed metabolic bone disease with focal insufficiency fractures. Marked extraosseous activity in both lungs and stomach was also visualized. On regular hemodialysis (HD) after 4 months, repeat pretransplant bone scan showed persistent uptake in lungs and stomach, representing altered calcium metabolism with microcalcifications. He underwent human leukocyte antigen (HLA) matched live donor renal transplantation, started on immune-suppression and steroids. Posttransplant bone scan at 20 days revealed no definite interval change, but bone scan performed approximately 17 months posttransplant showed resolving metabolic bone disease and the tracer uptake in the lungs and stomach was no more visualized. Patient clinically followed-up until the date (February 2013) is asymptomatic with serum creatinine of 1.5 mg/dl, no bone scan done.
Keywords
99mTc-MDP
bone scan
chronic kidney disease
gastric uptake
hemodialysis
lung uptake
INTRODUCTION
Extra skeletal uptake of technetium-99m (99mTc) phosphate and phosphonate radiopharmaceuticals is reported in a wide variety of conditions.[1] In both malignant and nonmalignant conditions, impaired renal function with consequent decreased phosphate excretion is a prerequisite for this phenomenon.[2] Extraosseous pulmonary calcification (PC) is found most commonly in end-stage renal disease (ESRD) patients on chronic hemodialysis (HD) therapy.[3] In our patient, pre-transplant whole body bone scan revealed lung and stomach uptake, which completely resolved in 17 months post-transplant bone scan. This case report highlights the importance of normalization of renal function and disappearance of insufficiency fractures along with the extraosseous 99mTc-methylene diphosphonate (MDP) uptake.
CASE REPORT
A 25-year young male, chronic kidney disease (CKD) patient, on HD for 3-4 months, developed bone pains. Patient had high creatinine (5.2 mg/dl) and serum phosphorus, low albumin (normal 0.8-1.2), and normal calcium. Pretransplant bone scan [Figure 1a and b] revealed insufficiency fractures involving the medial and lateral cortices of distal shaft of both femora and medial cortex of mid shaft of bilateral tibiae with periarticular increased radiotracer. Both the kidneys appeared small in size, with no definite tracer activity visualization in the bladder; but extraosseous activity noted in both lungs and stomach. 99mTc-MDP labeling was greater than 98%. Patient was regularly dialyzed and serum parathyroid hormone level was always low. Second bone scan [Figure 2] done 4 months later revealed no definite change. Patient underwent human leukocyte antigen (HLA) matched live donor (mother) renal transplantation. Posttransplant, patient was on tacrolimus, mycofenolate mofetil, and steroids. Serum creatinine reduced to 1.2 mg/dl with normal calcium and phosphorus. Bone scan [Figure 3] performed 20 days posttransplant showed no definite interval change. On follow-up, patient developed acute graft dysfunction, serum creatinine became 3.6 mg/dl. Patient complained of bone pains more in legs and thighs. A repeat bone scan (17 months posttransplant) was performed which revealed [Figure 4] no lung or stomach uptake, resolving metabolic bone disease and resolved insufficiency fractures. Patient clinically followed-up until February 2013, asymptomatic and serum creatinine of 1.5 mg/dl, no bone scans performed.
DISCUSSION
Gastric uptake has been described in patients with hypercalcemia either from tumors such as myeloma and breast carcinoma,[4] or from metabolic diseases such as renal insufficiency and milk-alkali syndrome.[5] In both malignant and nonmalignant conditions, impaired renal function with consequent decreased phosphate excretion is a prerequisite for this phenomenon,[2] our patient is a case of CKD with hyperphosphatemia. PC in hemodialyzed patients may be detected by 99mTc-MDP scanning.[6] Extraosseous PC is found most commonly in ESRD patients on chronic HD therapy.[3] In the lungs, calcium deposits have been found in the interstitium of the alveolar septum, bronchiole walls, in the large airways, and even in the walls of the pulmonary vessels.[7] Elevated stomach uptake of 99mTc-MDP can be due to free pertechnetate, to dystrophic, and to metastatic calcification.[8] In our case, the labeling of radiopharnmaceutical was 98% and was injected immediately after preparation. The kidneys, the lungs, and the stomach are the three main organs in the body where acids are secreted.[4] There is a local tissue alkalinity in the region of these acid producing cells, which has been suggested to predispose these tissues to metastatic calcification.[4] With the normalization of both calcium and phosphate metabolism and improved kidney function, new formation of 99mTc-MDP avid amorphous calcium phosphate, had ceased,[9] we noted complete disappearance of lungs and stomach uptake in 99mTc-MDP bone scan 17 months post-transplant. In any case of elevated 99mTc-MDP uptake in the stomach and/or lungs, vitamin D intoxication should be considered,[9] but our patient had normal vitamin D levels. Insufficiency fracture is an important diagnosis to make because survival may be improved if specific management is used.[10] This case report highlights the importance of normalization of renal function and disappearance of insufficiency fractures along with the extraosseous 99mTc-MDP uptake.
Source of Support: Nil.
Conflict of Interest: None declared.
REFERENCES
- Radionuclide imaging of nonneoplastic soft tissue disorders. Semin Nucl Med. 1981;11:277-88.
- [Google Scholar]
- Uptake of bone imaging agents by diffuse pulmonary metastatic calcification. AJR Am J Roentgenol. 1977;129:871-4.
- [Google Scholar]
- Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med. 2002;165:1654-69.
- [Google Scholar]
- Resolution of metastatic calcification revealed by bone scanning: Case report. J Nucl Med. 1977;18:890-2.
- [Google Scholar]
- Tc-99m-MDP bone scanning detection of gastric calcification. Clin Nucl Med. 1980;5:546-7.
- [Google Scholar]
- Pulmonary calcification in hemodialyzed patients detected by technetium-99m diphosphonate scanning. Kidney Int. 1980;18:95-102.
- [Google Scholar]
- Pulmonary calcification: Scanning electron microscopic and X-ray energy-dispersive analysis. Arch Pathol Lab Med. 1979;103:252-7.
- [Google Scholar]
- ExtraosseousTc-99m MDP uptake: A pathophysiologic approach. Radiographics. 1993;13:715-34.
- [Google Scholar]
- Clinical and scintigraphic evaluation of insufficiency fractures in the elderly. Nucl Med Commun. 2007;28:179-85.
- [Google Scholar]